BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Ben Haynor does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ICCMIcecure Medical | Buy | $2.90 | Mar 2024 | +0.3% | Miss |
 PROFProfound Medical Corp | Buy | $10.80 | Mar 2024 | −17.7% | Hit |
| PROFProfound Medical Corp | Buy | $12.75 | Jan 2024 | +2.7% | Miss |
 EVGNEvogene | Buy | $1.85 | Oct 2023 | −66.3% | Miss |
 NNOXNano X Imaging Ltd | Buy | $14.50 | Sep 2023 | −40.2% | Miss |
| ICCMIcecure Medical | Buy | $4.00 | Aug 2023 | −56.2% | Miss |
 NMTCNeuroone Medical Technologies Corp | Buy | $2.20 | Aug 2023 | −41.3% | Miss |
 DRIODarioHealth Corp | Buy | $4.10 | Aug 2023 | −81.4% | Miss |
 BEATHeartbeam Inc | Buy | $5.55 | May 2023 | +9.9% | Miss |
| PROFProfound Medical Corp | Buy | $15.75 | May 2023 | −54.5% | Miss |
 SRTSSensus Healthcare Inc | Buy | $7.00 | May 2023 | +21.4% | Miss |
 NSPRInspireMD Inc | Buy | $5.15 | Mar 2023 | +105.7% | Miss |
 CLGNCollplant Biotechnologies Ltd | Buy | $22.75 | Feb 2023 | −65.2% | Miss |
| SRTSSensus Healthcare Inc | Buy | $14.50 | Feb 2023 | −50.4% | Miss |
| BEATHeartbeam Inc | Buy | $10.00 | Dec 2022 | −66.5% | Miss |
| DRIODarioHealth Corp | Buy | $7.50 | Nov 2022 | −78.9% | Miss |
| SRTSSensus Healthcare Inc | Buy | $16.50 | Nov 2022 | −68.0% | Miss |
 MYOMyomo Inc | Buy | $6.70 | Jul 2022 | −69.1% | Miss |
| NSPRInspireMD Inc | Buy | $0.70 | Oct 2020 | −52.4% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.